Clinical case: idelalisib-induced immunoglobulin flare

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F17%3A43913277" target="_blank" >RIV/00216208:11120/17:43913277 - isvavai.cz</a>

Alternative codes found

RIV/00064173:_____/17:N0000017

Result on the web

<a href="http://dx.doi.org/10.1080/08923973.2017.1318912" target="_blank" >http://dx.doi.org/10.1080/08923973.2017.1318912</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1080/08923973.2017.1318912" target="_blank" >10.1080/08923973.2017.1318912</a>

Result language

angličtina

Original language name

Clinical case: idelalisib-induced immunoglobulin flare

Original language description

IgM flare is a transient, treatment-induced, increase of monoclonal IgM levels in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) patients. Until recently this phenomenon was observed in patients treated with Cladribine and Rituximab. Here we report a case of a heavily pretreated chronic lymphocytic leukemia patient with an atypically high immunoglobulin production who developed clinically significant immunoglobulin flare following Idelalisib treatment.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30102 - Immunology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2017

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Immunopharmacology and Immunotoxicology

ISSN

0892-3973

e-ISSN

—

Volume of the periodical

39

Issue of the periodical within the volume

4

Country of publishing house

GB - UNITED KINGDOM

Number of pages

2

Pages from-to

251-252

UT code for WoS article

000403934300011

EID of the result in the Scopus database

2-s2.0-85019595656